Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?

Radiotherapy and Oncology

Volumn 114, Issue 2, 2015, Pages 276-281

  Vanneste, Ben G L ^a   Pijls Johannesma, Madelon ^a,b   Van De Voorde, Lien ^a   Van Lin, Emile N ^c   Van De Beek, Kees ^d   Van Loon, Judith ^a   Ramaekers, Bram L ^a,d   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Health Insurance Company CZ   (Netherlands)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness; Prostate cancer; Radiotherapy; Spacer; Toxicity reduction

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH CARE COST; HOSPITAL CHARGE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY ADJUSTED LIFE YEAR; RADIOTHERAPY EQUIPMENT; RADIOTHERAPY SPACER; TOXICITY; ADVERSE EFFECTS; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DISEASE COURSE; ECONOMICS; PROBABILITY; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION INJURIES;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; HUMANS; MALE; MARKOV CHAINS; PROSTATIC NEOPLASMS; QUALITY-ADJUSTED LIFE YEARS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84926228219     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.01.005     Document Type: Article

References (31)

1. J.A. Talcott, J. Manola, and J.A. Clark Time course and predictors of symptoms after primary prostate cancer therapy J Clin Oncol 21 2003 3979 3986
2. R.J. Smeenk, and E.N.J.T. van Lin Application of anorectal sparing devices in prostate radiotherapy Radiother Oncol 106 2013 155 156
3. P.J. Prada, J. Fernández, and A.A. Martinez Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients Int J Radiat Oncol Biol Phys 69 2007 95 102
4. R.B. Wilder, G.A. Barme, and R.F. Gilbert Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 77 2010 824 830
5. W.R. Noyes, C.C. Hosford, and S.E. Schultz Human collagen injections to reduce rectal dose during radiotherapy Int J Radiat Oncol Biol Phys 82 2012 1918 1922
6. M. Uhl, B. van Triest, M.J. Eble, D.C. Weber, K. Herfarth, and T.L. De Weese Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial Radiother Oncol 106 2013 215 219
7. M. Pinkawa, N.E. Corral, and M. Caffaro Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer Radiother Oncol 100 2011 436 441
8. C. Melchert, E. Gez, and G. Bohlen Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study Radiother Oncol 106 2013 210 214
9. R. Valdagni, M.W. Kattan, and T. Rancati Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome Int J Radiat Oncol Biol Phys 82 2012 1957 1966
10. S.R. Hummel, M.D. Stevenson, E.L. Simpson, and J. Staffurth A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer Clin Oncol (R Coll Radiol) 24 2012 e159 e167
11. Common Terminology Criteria for Adverse Events 4.0 (CTCAE). (http://ctep.cancer.gov/protocolDevelopment/electronic-applications/ctc.htm).
12. D.Y. Song, K.K. Herfarth, and M. Uhl A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes Int J Radiat Oncol Biol Phys 87 2013 81 87
13. M.F. Drummond, M.J. Sculpher, and G.W. Torrance Methods for the economic evaluation of health care programmes 2005 Oxford University Press Oxford
14. J.C. Hodges, Y. Lotan, and T.P. Boike Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer J Oncol Pract 8 2012 31 37
15. Health Care Insurance Board Guidelines for pharmaco-economic research 2012 Health Care Insurance Board Diemen [in Dutch]
16. Hakkaart-van Roijen L, Tan S, Bouwmans C, et al. Manual for Costing Research (in Dutch). Amstelveen: College voor zorgverzekeringen [Health Care Insurance Board]; 2010.
17. Council for Public Health and Health Care Sensible and sustainable care 2006 Council for Public Health and Health Care Zoetermeer
18. B.A. van Hout, M.J. Al, G.S. Gordon, and F.F. Rutten Costs, effects and C/E-ratios alongside a clinical trial Health Econ 3 1994 309 319
19. M.J. Zelefsky, Z. Fuks, and S.A. Leibel Intensity-modulated radiation therapy for prostate cancer Semin Radiat Oncol 12 2002 229 237
20. A. Briggs Handling uncertainty in economic evaluation and presenting the results M.M. Drummond, Economic evaluation in health care 2001 Oxford University Press Oxford, United Kingdom 173 214
21. A. Al-Mamgani, W.D. Heemsbergen, S.T. Peeters, and J.V. Lebesque Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer Int J Radiat Oncol Biol Phys 73 2009 685 691
22. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
23. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
24. C. Fiorino, R. Valdagni, T. Rancati, and G. Sanguineti Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167
25. E.H. Huang, A. Pollack, and L. Levy Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 54 2002 1314 1321
26. R.C. Susil, T.R. McNutt, T.L. DeWeese, and D. Song Effects of prostate-rectum separation on rectal dose from external beam radiotherapy Int J Radiat Oncol Biol Phys 76 2010 1251 1258
27. D.M. Herold, A.L. Hanlon, and G.E. Hanks Diabetes mellitus: a predictor of late radiation morbidity Int J Radiat Oncol Biol Phys 43 1999 475 479
28. C.G. Willett, C.J. Ooi, and A.L. Zietman Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms Int J Radiat Oncol Biol Phys 46 2000 995 998
29. D. Vordermark, M. Guckenberger, K. Baier, and K. Markert Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102) Int J Radiat Oncol Biol Phys 71 2008 316 317
30. NICE 2004. Guide to the Methods of Technology Appraisal.
31. D.C. Weber, T. Zilli, J.P. Vallee, M. Rouzaud, R. Miralbell, and L. Cozzi Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study Int J Radiat Oncol Biol Phys 84 2012 e311 e318